logo munafa.co.com

NEWS Gainers Losers
 Learn then Earn

 story : Inovio's stock is up after it shares new data from Phase 2 clinical trial for its COVID-19 vaccine candidate #FinanceUSA #StockMarketNEWS Shares of Inovio Pharmaceuticals Inc. gained 8.0% in premarket

@stockMarketNEWS Mon 10 May, 2021

Posted in: #FinanceUSA #StockMarketNEWS

Inovio's stock is up after it shares new data from Phase 2 clinical trial for its COVID-19 vaccine candidate #FinanceUSA #StockMarketNEWS
Shares of Inovio Pharmaceuticals Inc. gained 8.0% in premarket trading on Monday after the company said its experimental COVID-19 vaccine was safe and also triggered antibody titers in 400 or so adult participants in a Phase 2 clinical trial. The results were published Friday as a preprint. Inovio has largely struggled to move its two-dose, DNA-based COVID-19 vaccine candidate forward. A Phase 3 clinical study is still on hold, due to "remaining questions" from the Food and Drug Administration about a device used for administering the shots. Inovio said in April that the Department of Defense stopped funding development of its COVID-19 vaccine, and the Phase 3 clinical trial for the still-investigational shots will largely be conducted outside of the U.S. Inovio's stock is down 22.6% for the year, while the S&P 500 is up 12.7%.


Munafa USA Munafa India Munafa NSE


Report

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

 Learn then Earn
Back to top | Use Dark Theme